Sensocure is an ambitious Norwegian medical technology company, established in 2011. Our first target is to commercialise IscAlert™, the world's first implantable micro sensor monitoring local tissue pCO2 which provides the ability to identify the onset of ischemic events before irreversible injury occurs.